BayWa’s, Rescue

BayWa’s Rescue Plan Hands Control to a Trustee as Criminal Probes Complicate the Recovery

Published on 07/28/2026 at 07:31 | Redaktion boerse-global.de

BayWa's majority shareholders transfer voting rights to a trustee as part of a rescue plan extending to 2030, with a €220M capital condition for reversion.

BayWa Restructuring: Shareholders Lose Control, Creditors Demand €220M Capital Injection
BayWa’s Rescue Plan Hands Control to a Trustee as Criminal Probes Complicate the Recovery Illustration mit AI erstellt übermittelt durch boerse-global.de

The restructuring of BayWa has entered uncharted territory. The Munich-based agricultural and energy group’s two largest shareholders — Bayerische Raiffeisen-Beteiligungs-AG and Raiffeisen Agrar Invest AG — have transferred their combined 67.1 percent stake’s voting rights to a trustee, a move that effectively strips the longtime owners of immediate control over their shares. The handover, which took effect on Saturday, is part of an expanded rescue blueprint that extends the company’s rehabilitation period through the end of 2030.

The arrangement comes with a significant string attached. Under the terms disclosed by FINANCE Magazin, the voting rights will only revert to the original owners if they inject at least €220 million in fresh capital by 2029. Until then, an external trustee will steer the decision-making power tied to the majority stake — a stark illustration of how far the company’s creditors have pushed to secure their position.

Debt Conversion and a Stretched Timeline

At the heart of the restructuring agreement, which BayWa reached in principle with its major financing partners and shareholders at the end of June, is a plan to convert up to €700 million of financial liabilities into subordinated instruments. This operation is designed to strengthen the group’s economic equity without requiring an immediate cash infusion from outside. The extension of the restructuring period to 2030 gives the company more breathing room, but it also signals that the recovery will be a marathon, not a sprint.

The creditors’ willingness to accept a haircut was already visible in the books of BayWa’s closest banking partners. The Bavarian Volks- und Raiffeisenbanken wrote down a €220 million promissory note loan to BayWa by 60 percent in their annual accounts — a blunt acknowledgment that even the cooperative banks most closely tied to the group no longer expect full repayment.

Should investors sell immediately? Or is it worth buying BayWa?

Criminal Investigations Add to the Pressure

While the financial rescue plan takes shape, the past is catching up with the company. The Munich public prosecutor’s office has opened investigations into several former members of BayWa’s executive board on suspicion of breach of trust linked to the expansion strategy of recent years. The probe, reported by Der Tagesspiegel, targets the very business policies that critics say drove the group into its current crisis.

The supervisory board has already undergone a shake-up. In June, a court appointed Ines Kapphan, Solveig Menard-Galli, and Christine Rittner-Koch as new members, replacing Michael Höllerer, Monika Hohlmeier, and Monique Surges. The timing of the supervisory overhaul coincides with the intensification of legal scrutiny, signaling a clean break at the top while the old guard faces potential liability.

Leadership Departure and Pending Milestones

The management turmoil is far from over. CEO Dr. Frank Hiller is set to leave the company on July 31 — this Friday — following the supervisory board’s announcement of his departure back in March. His exit comes at a delicate moment: the preliminary agreement reached in late June still needs to be converted into a legally binding contract with all creditors, a process expected to conclude in the autumn.

Investors will have to wait even longer for clarity on the group’s financial health. The audited consolidated financial statements for the 2025 fiscal year are not expected until the fourth quarter of 2026, delayed by complex impairment tests. For context, BayWa’s last published annual results showed a net loss of roughly €1.6 billion, driven largely by write-downs tied to the restructuring. The group also flagged planning deviations at its BayWa r.e. renewable energy subsidiary for the 2026–2028 period, triggered by regulatory changes in the U.S. and Europe.

Shares Stuck Near the Floor

The stock market has taken a dim view of the unfolding saga. On Monday, BayWa shares closed at €10.10, down 0.98 percent from the previous session. That leaves the stock down 39.88 percent since the start of the year and just 3.91 percent above its 52-week low of €9.72, set on June 19. The shares are essentially trading at the bottom of their range, reflecting the deep uncertainty surrounding the company’s future.

BayWa at a turning point? This analysis reveals what investors need to know now.

Some liquidity has been generated. In the first quarter, BayWa completed the sale of the Cefetra Group for €125 million, and the associated deconsolidation reduced bank debt by around €600 million. The proceeds went entirely toward repaying bank liabilities. The sale process for the 51 percent stake in BayWa r.e. remains ongoing and is considered critical to the group’s future capital position. Meanwhile, the company has also committed to divesting its heat and mobility business units by the end of 2029.

For now, BayWa’s shareholders are caught between a restructuring plan that offers a path forward — but only if the conditions are met by 2029 — and a criminal investigation that could yet unearth further liabilities. The autumn, when the binding creditor agreement is expected and the audited accounts are due, will be the next real test of whether the recovery is on track or merely delayed.

Ad

BayWa Stock: New Analysis - 28 July

Fresh BayWa information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BayWa analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0005194005 | BAYWA’S | boerse | 69890071 |